Business Context and Reporting Period
This Form 8-K Current Report was filed by BlueLinx Holdings Inc. on July 11, 2023, regarding events occurring on July 6, 2023. The filing addresses significant changes in executive leadership, specifically the resignation of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
This filing does not contain operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements and transition terms.
Material Changes
The primary material change is the departure of Kelly C. Janzen, Senior Vice President, Chief Financial Officer, and Treasurer, effective August 31, 2023. Concurrently, R. Andrew Wamser, Jr. was appointed as Senior Vice President and Chief Financial Officer-Elect, effective July 17, 2023, assuming the full role on August 4, 2023.
Management Commentary, Risks, and Unusual Items
Executive Compensation and Transition Terms:
- R. Andrew Wamser, Jr. (Incoming CFO):
- Annual base salary: $575,000.
- Short-term incentive target: 80% of base salary.
- Sign-on equity: $1,000,000 in restricted stock units (vesting ratably over three years).
- Long-term incentive eligibility: Annual awards with a value of no less than 125% of base salary.
- Separation benefits: 100% of base salary plus pro-rated bonus for termination without cause; 200% of base salary plus accelerated equity vesting for change in control.
- Kelly C. Janzen (Outgoing CFO):
- Will receive two-thirds of her target 2023 short-term incentive bonus.
- Acceleration of vesting for 4,369 restricted stock units (scheduled for 2024) and 1,339 units (scheduled for 2025) on the termination date.
- Continued base salary and expense reimbursement through August 31, 2023.
- Six years of director and officer liability coverage post-termination.
Risks and Contingencies:
- Payments and benefits for both executives are conditioned upon the execution and non-revocation of a customary general release of claims.
- The filing explicitly states that Ms. Janzen's resignation is not due to any conflicts regarding financial reporting or accounting principles.
Investor Verification Checklist
- Verify the exact effective dates for the transition of CFO duties (July 17, 2023, for appointment; August 4, 2023, for full assumption of role).
- Review the definitive employment agreement for Mr. Wamser and the transition agreement for Ms. Janzen, which are scheduled to be filed as exhibits to the Form 10-Q for the quarter ended September 30, 2023.
- Confirm the total equity value implications of the accelerated vesting for Ms. Janzen and the sign-on grant for Mr. Wamser.
- Monitor the company's 2023 annual proxy statement for details on the broader executive benefit plans referenced in this filing.